Clinical trial / 2016
Apoaequorin supplementation for 90 days significantly improved verbal learning and recall in community-dwelling adults with memory concerns.
In the Madison Memory Study, 218 adults aged 40-91 years with self-reported memory concerns were randomized to receive either an apoaequorin supplement or a matched placebo for 90 days. Cognitive function was evaluated using the computerized CogState International Shopping List (ISL) and ISL-Delayed Recall (ISL-DR) at baseline and multiple points during the study. The apoaequorin group showed statistically significant improvements in verbal learning on the ISL and recall on the ISL-DR over 90 days, and the supplement was well tolerated.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 218 community-dwelling adults aged 40-91 years with self-reported memory concerns
- What was measured
- Verbal learning and recall measured by the CogState ISL and ISL-Delayed Recall tasks
THE PAPER
Effects of a Supplement Containing Apoaequorin on Verbal Learning in Older Adults in the Community.
Moran DL, Underwood MY, Gabourie TA, Lerner KC. Adv Mind Body Med, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.